Comparison - AIBT - OTC PK

Weiss Ratings	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Rating	E
Reward Index	Very Weak
Risk Index	Very Weak
Risk Grade	E+
Reward Grade	E

Rating Factors	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Very Weak
Efficiency Index	Very Weak
Solvency Index	Very Weak
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Beta	0.42

Price History	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	-41.94%
30-Day Total Return	-83.64%
60-Day Total Return	60.71%
90-Day Total Return	21.62%
Year to Date Total Return	16.13%
1-Year Total Return	-81.96%
2-Year Total Return	-70.64%
3-Year Total Return	-99.10%
5-Year Total Return	--
52-Week High % Change	-85.00%
52-Week Low % Change	172.73%

Price	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$0.14
52-Week Low Price	$0.01
52-Week Low Price (Date)	Jan 24, 2025
52-Week High Price (Date)	Feb 28, 2025

Valuation	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Market Cap	886.01K
Enterprise Value	1.95M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-0.14
Earnings Per Share Growth	34.85%
Price/Earnings To Growth	--
Price/Sales (TTM)	--
Price/Book (Q)	-0.03
Enterprise Value/Revenue (TTM)	--
Price	$0.02
Enterprise Value/EBITDA (TTM)	-2.55
Enterprise Value/EBIT	-1.47
Market Cap Category	Nano Cap

Dividends and Shares	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	8.10M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Phone Number	954 233 3511
Address	100 SE 2nd Street Miami, FL 33131
Website	www.mycotopiatherapies.com
Country	United States
Year Founded	--

Profitability	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	--
Profit Margin	--

Management Effectiveness	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-84.58%
Return on Equity	--

Income Statement	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	--
Total Revenue (TTM)	--
Revenue Per Share	--
Gross Profit (TTM)	--
EBITDA (TTM)	-765.60K
EBIT (TTM)	-1.33M
Net Income (TTM)	-1.65M
Net Income Avl. to Common (TTM)	-1.65M
Total Revenue Growth (Q YOY)	--
Earnings Growth (Q YOY)	-49.04%
EPS Diluted (TTM)	-0.14
EPS Diluted Growth (Q YOY)	-174.40%

Balance Sheet	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	202.40K
Cash Per Share (Q)	$0.02
Total Current Assets (Q)	203.10K
Total Preferred Equity (Q)	--
Total Equity (Q)	-3.36M
Current Ratio (Q)	0.041
Book Value Per Share (Q)	-$0.61
Total Assets (Q)	1.64M
Total Current Liabilities (Q)	5.00M
Total Debt (Q)	1.27M
Total Liabilities (Q)	5.00M
Total Common Equity (Q)	-3.36M

Cash Flow	AIBT - OTC PK	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	--
Cash from Financing (TTM)	165.00K
Net Change in Cash (TTM)	-114.60K
Levered Free Cash Flow (TTM)	2.27M
Cash from Operations (TTM)	-279.60K